Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MC1R | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | ATP5B | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | DARS2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
mRNA | MAL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | PPOX | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
mRNA | GSTM3 | FIMM | pan-cancer | AAC | 0.46 | 0.009 |
mRNA | UROS | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | DNAJB5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | PRDM11 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | HECTD2 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |